Cell Therapy Account Director - Southwest (Remote)

Pierre Fabre; United States; Remote; USD 170,000 - 250,000; Full time

Benefits offered by this job

Medical, dental, and vision coverage

401(k) retirement plan

PTO and holidays

Parental leave

Job summary

Pierre Fabre seeks a senior CTAD to lead the US launch of Tab-cel, focusing on EBV+ PTLD patients in a high-impact, start-up environment. You will build relationships with experts, map patient journeys, and drive disease awareness pre- and post-approval.

Responsibilities include cross-functional leadership, territory business planning, and educator roles to ensure rapid, compliant adoption of allogeneic cell therapy across leading institutions.

Qualifications

• Bachelor’s Degree required.
• 10+ years in biopharma.
• Deep expertise in cell or gene therapy service lines.
• Collaborative in a matrix environment.
• Strong scientific aptitude and ability to convey complex therapies.
• Sales experience in ultra-rare diseases, CGT preferred.

Responsibilities

• Lead disease awareness and onboarding for allogeneic cell therapy launch.
• Develop relationships with clinical and non-clinical experts to map unmet needs.
• Drive territory plans with KPIs, engage with hospitals and transplant centers.
• Coordinate cross-functionally with marketing, medical affairs, and operations.
• Educate physicians on disease state, treatment options, and patient journey.
• Promote Tab-cel Ebvallo through compliant activities and materials.

Skills

Sales experience

Account management

Cross-functional work

Scientific aptitude

Education

Bachelor’s Degree

Job description

Pierre Fabre seeks a senior CTAD to lead the US launch of Tab-cel, focusing on EBV+ PTLD patients in a high-impact, start-up environment. You will build relationships with experts, map patient journeys, and drive disease awareness pre- and post-approval.

Responsibilities include cross-functional leadership, territory business planning, and educator roles to ensure rapid, compliant adoption of allogeneic cell therapy across leading institutions.